Introduction to Dopaminergic Nigrostriatal

Sentence Examples

Discover more insights into Dopaminergic Nigrostriatal

Keywords frequently search together with Dopaminergic Nigrostriatal

Narrow sentence examples with built-in keyword filters

Dopaminergic Nigrostriatal sentence examples within dopaminergic nigrostriatal neuron

dopaminergic nigrostriatal neuron

Recent evidence supports its utility as in vivo proof of degenerative parkinsonisms, and DAT imaging has been proposed as a potential surrogate marker for dopaminergic nigrostriatal neurons.

Molecular Imaging of the Dopamine Transporter

dopaminergic nigrostriatal neuron

BackgroundParkinson’s disease (PD), the most common neurodegenerative movement disorder, is characterized by dopaminergic nigrostriatal neuron loss and brain accumulation of Lewy bodies, protein aggregates mainly composed of α-synuclein.

NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice

More dopaminergic nigrostriatal neuron sentences More Sentences

Dopaminergic Nigrostriatal sentence examples within dopaminergic nigrostriatal pathway

dopaminergic nigrostriatal pathway

P2X7 receptor antagonism with Brilliant Blue G (BBG) at a dose of 75 mg/kg re-established the dopaminergic nigrostriatal pathway in rats injured with 6-OHDA.

P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson’s Disease

dopaminergic nigrostriatal pathway

As main motor symptoms of PD are related to degeneration of the dopaminergic nigrostriatal pathway, treatment of these patients, theoretically, may be based on transplantation of dopamine-producing neurons into the striatum.

Neurotransplantation: the Time Has Come?

More dopaminergic nigrostriatal pathway sentences More Sentences

More Dopaminergic Nigrostriatal sentence examples
10.3390/cells8080872

Recent evidence supports its utility as in vivo proof of degenerative parkinsonisms, and DAT imaging has been proposed as a potential surrogate marker for dopaminergic nigrostriatal neurons.

Molecular Imaging of the Dopamine Transporter

More Dopaminergic Nigrostriatal sentence examples
10.1186/s40035-019-0154-z

BackgroundParkinson’s disease (PD), the most common neurodegenerative movement disorder, is characterized by dopaminergic nigrostriatal neuron loss and brain accumulation of Lewy bodies, protein aggregates mainly composed of α-synuclein.

NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice

More Dopaminergic Nigrostriatal sentence examples
10.1093/hmg/ddz040

In the dopaminergic nigrostriatal tract, synaptic endings but not neuronal cell bodies were affected.

Disturbed neurotransmitter homeostasis in ether lipid deficiency

More Dopaminergic Nigrostriatal sentence examples
10.1016/j.celrep.2019.01.044

In vivo, optogenetic activation of this pathway drives reinforcement in a DA D1 receptor-dependent manner, and chemogenetic suppression of the rILN reduces dopaminergic nigrostriatal terminal activity as measured by fiber photometry.

Activation of the Rostral Intralaminar Thalamus Drives Reinforcement through Striatal Dopamine Release

More Dopaminergic Nigrostriatal sentence examples
10.3389/fncel.2019.00476

P2X7 receptor antagonism with Brilliant Blue G (BBG) at a dose of 75 mg/kg re-established the dopaminergic nigrostriatal pathway in rats injured with 6-OHDA.

P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson’s Disease

More Dopaminergic Nigrostriatal sentence examples
10.1016/j.bbr.2019.01.004

Here we studied the behavioral structure of the animals after 21 days of 6‐OHDA‐induced lesion of the dopaminergic nigrostriatal system.

Effects of Substantia Nigra pars compacta lesion on the behavioral sequencing in the 6-OHDA model of Parkinson’s disease

More Dopaminergic Nigrostriatal sentence examples
10.1134/S0362119719080048

As main motor symptoms of PD are related to degeneration of the dopaminergic nigrostriatal pathway, treatment of these patients, theoretically, may be based on transplantation of dopamine-producing neurons into the striatum.

Neurotransplantation: the Time Has Come?

Learn more from Dopaminergic Nigrostriatal

Keywords related to Dopaminergic

Keywords related to Nigrostriatal

Dopaminergic Nigrostriatal
Encyclopedia

What is/are Dopaminergic Nigrostriatal?

Dopaminergic Nigrostriatal - Recent evidence supports its utility as in vivo proof of degenerative parkinsonisms, and DAT imaging has been proposed as a potential surrogate marker for dopaminergic nigrostriatal neurons. [1] BackgroundParkinson’s disease (PD), the most common neurodegenerative movement disorder, is characterized by dopaminergic nigrostriatal neuron loss and brain accumulation of Lewy bodies, protein aggregates mainly composed of α-synuclein. [2] In the dopaminergic nigrostriatal tract, synaptic endings but not neuronal cell bodies were affected. [3] In vivo, optogenetic activation of this pathway drives reinforcement in a DA D1 receptor-dependent manner, and chemogenetic suppression of the rILN reduces dopaminergic nigrostriatal terminal activity as measured by fiber photometry. [4] P2X7 receptor antagonism with Brilliant Blue G (BBG) at a dose of 75 mg/kg re-established the dopaminergic nigrostriatal pathway in rats injured with 6-OHDA. [5] Here we studied the behavioral structure of the animals after 21 days of 6‐OHDA‐induced lesion of the dopaminergic nigrostriatal system. [6] As main motor symptoms of PD are related to degeneration of the dopaminergic nigrostriatal pathway, treatment of these patients, theoretically, may be based on transplantation of dopamine-producing neurons into the striatum. [7]

dopaminergic nigrostriatal neuron

Recent evidence supports its utility as in vivo proof of degenerative parkinsonisms, and DAT imaging has been proposed as a potential surrogate marker for dopaminergic nigrostriatal neurons. [1] BackgroundParkinson’s disease (PD), the most common neurodegenerative movement disorder, is characterized by dopaminergic nigrostriatal neuron loss and brain accumulation of Lewy bodies, protein aggregates mainly composed of α-synuclein. [2]

dopaminergic nigrostriatal pathway

P2X7 receptor antagonism with Brilliant Blue G (BBG) at a dose of 75 mg/kg re-established the dopaminergic nigrostriatal pathway in rats injured with 6-OHDA. [1] As main motor symptoms of PD are related to degeneration of the dopaminergic nigrostriatal pathway, treatment of these patients, theoretically, may be based on transplantation of dopamine-producing neurons into the striatum. [2]